LeadIQ logo
Learn more at LeadIQ.com

Insights

Global Presence Expansion Stallergenes Greer operates in over 40 countries with manufacturing facilities in Europe and the United States, indicating strong international distribution channels and potential for expanding market reach in emerging regions.

Strategic Acquisitions Recent acquisitions of Entomon s.r.l. and Palforzia demonstrate a focus on expanding allergen-specific therapies and diagnostic products, creating opportunities for sales of complementary allergy immunotherapy solutions.

Innovation & Product Portfolio With a dedicated focus on allergy therapeutics and precision medicine, there is potential to introduce new allergen immunotherapy products tailored to regional allergy profiles and patient needs.

Leadership & Market Focus Leadership changes and ongoing participation in industry events like EAACI 2025 suggest a proactive approach to innovation and maintaining leadership, providing opportunities for sales to align with upcoming product launches and developments.

Financial Strength With revenue ranging from 500 million to 1 billion USD and recent funding, Stallergenes Greer has strong financial backing, enabling investments in new therapies and partnership opportunities to expand market share.

Similar companies to STALLERGENES GREER

STALLERGENES GREER Tech Stack

STALLERGENES GREER uses 8 technology products and services including DB2, Microsoft Excel, Twemoji, and more. Explore STALLERGENES GREER's tech stack below.

  • DB2
    Database
  • Microsoft Excel
    Editors
  • Twemoji
    Font Scripts
  • LinkedIn
    Online Community Software
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Facebook
    Widgets

Media & News

STALLERGENES GREER's Email Address Formats

STALLERGENES GREER uses at least 1 format(s):
STALLERGENES GREER Email FormatsExamplePercentage
First.Last@stallergenesgreer.comJohn.Doe@stallergenesgreer.com
70%
FLast@stallergenesgreer.comJDoe@stallergenesgreer.com
22%
FirLast@stallergenesgreer.comJohDoe@stallergenesgreer.com
5%
Last.First@stallergenesgreer.comDoe.John@stallergenesgreer.com
3%

Frequently Asked Questions

Where is STALLERGENES GREER's headquarters located?

Minus sign iconPlus sign iconSTALLERGENES GREER's main headquarters is located at 76b Zugerstrasse Baar, Zug 6340 Switzerland. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is STALLERGENES GREER's phone number?

Minus sign iconPlus sign icon You can contact STALLERGENES GREER's main corporate office by phone at
+1-781-878-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is STALLERGENES GREER's official website and social media links?

Minus sign iconPlus sign iconSTALLERGENES GREER's official website is stallergenesgreer.com and has social profiles on LinkedInCrunchbase.

What is STALLERGENES GREER's SIC code NAICS code?

Minus sign iconPlus sign iconSTALLERGENES GREER's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does STALLERGENES GREER have currently?

Minus sign iconPlus sign iconAs of March 2026, STALLERGENES GREER has approximately 1.1K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer And Chairman Of The Board: A. A.Chief Executive Officer: R. R.Chief Medical Officer: E. R.. Explore STALLERGENES GREER's employee directory with LeadIQ.

What industry does STALLERGENES GREER belong to?

Minus sign iconPlus sign iconSTALLERGENES GREER operates in the Pharmaceutical Manufacturing industry.

What technology does STALLERGENES GREER use?

Minus sign iconPlus sign iconSTALLERGENES GREER's tech stack includes DB2Microsoft ExcelTwemojiLinkedInPHPX-Content-Type-OptionsGoogle AnalyticsFacebook.

What is STALLERGENES GREER's email format?

Minus sign iconPlus sign iconSTALLERGENES GREER's email format typically follows the pattern of First.Last@stallergenesgreer.com. Find more STALLERGENES GREER email formats with LeadIQ.

How much funding has STALLERGENES GREER raised to date?

Minus sign iconPlus sign icon As of March 2026, STALLERGENES GREER has raised $53M in funding. The last funding round occurred on Dec 01, 2016 for $53M.

When was STALLERGENES GREER founded?

Minus sign iconPlus sign iconSTALLERGENES GREER was founded in 2015.

STALLERGENES GREER

Pharmaceutical ManufacturingZug, Switzerland1001-5000 Employees

Stallergenes Greer is a global biopharmaceutical company specialising in allergy therapeutics through the research, development and commercialisation of allergen immunotherapy products and services. Supported by more than 100 years of expertise and innovation, our products are available for patients in over 40 countries.
Our purpose is to enable precision medicine to improve life for people with allergies. 
With more than 1,100 employees worldwide and manufacturing facilities in both Europe and the United States, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.

Link to our terms and conditions: https://bit.ly/3MsHqlk

Section iconCompany Overview

Headquarters
76b Zugerstrasse Baar, Zug 6340 Switzerland
Phone number
+1-781-878-****
Website
stallergenesgreer.com
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $53M

    STALLERGENES GREER has raised a total of $53M of funding over 1 rounds. Their latest funding round was raised on Dec 01, 2016 in the amount of $53M.

  • $500M$1B

    STALLERGENES GREER's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $53M

    STALLERGENES GREER has raised a total of $53M of funding over 1 rounds. Their latest funding round was raised on Dec 01, 2016 in the amount of $53M.

  • $500M$1B

    STALLERGENES GREER's revenue is estimated to be in the range of $500M$1B

Company Leadership

  • Stylized image of a person
    A. A.
    Chief Executive Officer And Chairman Of The Board
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. R.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. R.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. U.
    Vice President Dach And Managing Director Germany & Austria
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    T. N.
    President, Stallergenes Greer Americas
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Executive Assistant To Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. R.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. F.
    Chairman & Ceo
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.